Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Reports $9.7M in Charges for Headcount Reduction in Q3

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific spent about $9.7 million in costs related to severance of employees during the third quarter, the company said in its Form 10-Q filed on Friday.

The company, which has approximately 39,000 employees globally, did not disclose how many staffers were laid off during the quarter.

Thermo Fisher said that it spent the bulk of the costs associated with headcount reductions in its Specialty Diagnostics segment, $4.2 million. Severance-related costs in the Analytical Technologies segment totaled $3.0 million, while Laboratory Products and Services' headcount reduction costs were $2.4 million.

Corporate costs incurred from severance actions totaled $100,000, the company said.

In the second quarter, the company took charges of $12.8 million associated with a reduction in headcount of 340 employees in the second quarter, though it is unclear when the headcount reductions occurred. Through the first half of 2013, Thermo Fisher trimmed its payroll by about 655 employees.

Charges taken by the company through the first nine months of the year associated with a headcount reduction were $42.6 million, it said in its Form 10-Q.

Thermo Fisher, which is awaiting the completion of its $13.6 billion purchase of Life Technologies, said two weeks ago that its third quarter revenues increased 3 percent year over year to $3.19 billion.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.